# Viit Health Enters Commercial Deployment — Be Part of It

- Canonical URL: https://wefunder.com/feed/323853
- Entity ID: wefunder:feed_item:323853
- Published at: 2026-05-20 15:00:00 UTC
- Updated at: 2026-05-20 19:27:47 UTC

## Author
Luis Fernando Gomez

## Subject
Viit Health

## Content
Hello everyone!We are entering one of the most important stages in Viit Health’s journey.After years of development we are preparing our first large-scale deployment in Mexico and the United States.To support this next phase, Viit Health is opening a private round for accredited investors with preferred terms through WeFunder.We are raising $1.5M to help deploy our first 180 Viit Gen-4 units as part of our Cardiometabolic Risk Observation Programs (CROP) — a population-level monitoring model designed to help organizations identify cardiometabolic risk earlier, track health trends over time, and support preventive action at scale.This first deployment is already secured, and we are now opening a waiting list for next year. Our initial client pipeline includes three of the largest employers in Mexico and one of the largest community organizations in the United States.A New Model for Preventive HealthViit Health is building a faster, more accessible way to monitor cardiometabolic health.Our platform combines:Non-invasive, light-based measurements30-second biomarker readingsAI-based signal processingIndividual health reportsOrganizational dashboardsClinical supervision and validation workflowsPopulation-level risk stratificationLongitudinal monitoring over timeBut measurement alone is not enough.That is why we have partnered with DailyHuman to integrate behavioral support directly into the program.Together, Viit Health and DailyHuman are building a new preventive health model that connects physiological insight with daily behavior change.Viit helps organizations measure and observe cardiometabolic risk. DailyHuman helps participants translate those insights into healthier habits through its Longevity Lab, focused on self-awareness, coaching, reflections, and sustainable behavior change.As an additional layer, we have also partnered with InBody to provide body composition analysis, expand our research scope, and complement our observation and improvement methodology.These partnerships are central to our deployment strategy: we are not only helping organizations see risk earlier — we are helping them better understand cardiometabolic health and activate the behavioral support needed to reduce that risk over time.Investor Session We recently hosted a Viit Health Investor Session to present the company, the technology, the clinical progress, the commercial model, and our upcoming deployment strategy.In the session, we cover:The chronic disease problem we are addressingHow Viit’s non-invasive technology worksHow we translate information from the body into physiological signals, with Antonio A. García, PhD.How we extract the necessary information from those signals using AI, with Felix Agakov, PhD.Our clinical results to dateHow prevention can be supported through repeated observation, with Adriana Monroy, MD, PhD.Our business model and market opportunityOur CROP commercial deployment modelThe Viit Health + DailyHuman partnershipHow physiological insights can drive behavior change, with Stephen Dahmer, MD.Our competitive positioningOur team, traction, history, and roadmapThe private round and WeFunder campaignWatch the Investor Session here:Why NowNon-communicable diseases remain one of the largest health challenges in the world. Yet large-scale screening is still too slow, expensive, fragmented, and difficult to deploy frequently.Viit Health is designed to make preventive monitoring practical at scale.Through CROP, we can help employers, community organizations, clinics, public health programs, and institutional partners monitor cardiometabolic risk across large populations — quickly, affordably, and repeatedly.Our goal is to move prevention from an idea into an operational system.Private Round DetailsWe are raising $1.5M to support:Product and manufacturing: Preparation of the first Viit Gen-4 deployment units.Commercial activation: Deployment of the first 180 units through CROP programs in Mexico and the United States.Clinical and regulatory progress: Continued validation and preparation for future regulatory pathways.The offering page includes the full round details, preferred terms, and exclusive campaign perks available to qualifying investors.Join UsThis private campaign is an opportunity for accredited investors in the WeFunder community to participate in Viit Health’s launch phase as we move from clinical validation and product development into commercial deployment.If you are an accredited investor and would like to review the round, preferred terms, and campaign perks, please visit the offering page and join the private round.Help us measure what matters — and reshape the future of preventive healthcare!